These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2159095)

  • 1. Effects of metkephamid (LY127623), a selective delta opioid receptor agonist, on gastric function.
    Glavin GB; Pinsky C; Hall AM
    Life Sci; 1990; 46(15):1075-9. PubMed ID: 2159095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-tolerance studies distinguish morphine- and metkephamid-induced analgesia.
    Hynes MD; Frederickson RC
    Life Sci; 1982 Sep 20-27; 31(12-13):1201-4. PubMed ID: 6292609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central and peripheral sites of action for the protective effect of opioids of the rat stomach.
    Ferri S; Arrigo-Reina R; Candeletti S; Costa G; Murari G; Speroni E; Scoto G
    Pharmacol Res Commun; 1983 Apr; 15(4):409-18. PubMed ID: 6306698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naloxone-insensitive modulation of gastric acid output by [D-Met2,Pro5]enkephalinamide in rats.
    Till M; Szombath D; Gáti T; Székely JI
    Eur J Pharmacol; 1990 Jan; 175(3):355-8. PubMed ID: 2323351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-tolerance to metkephamid (LY127623) produced by morphine solution ingestion by mice.
    Leander JD
    Alcohol Drug Res; 1987; 7(5-6):321-5. PubMed ID: 3040022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opiate mechanisms in the central amygdala and gastric stress pathology in rats.
    Ray A; Henke PG; Sullivan RM
    Brain Res; 1988 Feb; 442(1):195-8. PubMed ID: 2834014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical pharmacology of metkephamid (LY127623), a Met-enkephalin analogue.
    Frederickson RC; Parli CJ; DeVane GW; Hynes MD
    NIDA Res Monogr; 1983 Apr; 43():150-6. PubMed ID: 6308452
    [No Abstract]   [Full Text] [Related]  

  • 8. Characterization of the opioid receptor type mediating inhibition of rat gastric somatostatin secretion.
    McIntosh CH; Jia X; Kowk YN
    Am J Physiol; 1990 Dec; 259(6 Pt 1):G922-7. PubMed ID: 1979718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular properties of metkephamid, a delta opioid receptor agonist, in man.
    Pasanisi F; Sloan L; Rubin PC
    Clin Sci (Lond); 1985 Feb; 68(2):209-13. PubMed ID: 2981652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Verapamil and nifedipine effects on gastric acid secretion and ulcer formation in rats.
    Glavin GB
    J Pharm Pharmacol; 1988 Jul; 40(7):514-5. PubMed ID: 2904996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium channel modulators: effects on gastric function.
    Glavin GB
    Eur J Pharmacol; 1989 Feb; 160(3):323-30. PubMed ID: 2714365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the selective I1 imidazoline receptor agonist, moxonidine, on gastric secretion and gastric mucosal injury in rats.
    Glavin GB; Smyth DD
    Br J Pharmacol; 1995 Feb; 114(4):751-4. PubMed ID: 7773534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of stress-induced gastric ulcers by mu- and delta-opioid agonists in the rat.
    Scoto GM; Parenti C
    J Physiol Paris; 1993; 87(6):385-8. PubMed ID: 8292989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of opioid receptors on gastric muscle cells by selective receptor protection.
    Grider JR; Makhlouf GM
    Am J Physiol; 1991 Jan; 260(1 Pt 1):G103-7. PubMed ID: 1670978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Supraspinal delta- and mu-opioid receptors mediate gastric mucosal protection in the rat.
    Gyires K; Rónai AZ
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1010-5. PubMed ID: 11356923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo studies with ICI 154,129, a putative delta receptor antagonist.
    Cowan A; Gmerek DE
    Life Sci; 1982 Nov 15-22; 31(20-21):2213-6. PubMed ID: 6298518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of quinacrine, a phospholipase A2 inhibitor on stress and chemically induced gastroduodenal ulcers.
    Al Moutaery AR; Tariq M
    Digestion; 1997; 58(2):129-37. PubMed ID: 9144302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of central and peripheral mu, delta and kappa opioid receptors in the mediation of gastric acid secretory effects in the rat.
    Fox DA; Burks TF
    J Pharmacol Exp Ther; 1988 Feb; 244(2):456-62. PubMed ID: 2831341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the novel anti-ulcer agent 1-(5'-oxohexyl)-3-methyl-7-propyl xanthine on experimental ulcers and gastric secretion in rats.
    Tanaka T; Bickel M; Herling AW; Sakurai M; Goto M; Hayashi S
    Arzneimittelforschung; 1989 Jun; 39(6):689-94. PubMed ID: 2775336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kynurenic acid attenuates experimental ulcer formation and basal gastric acid secretion in rats.
    Glavin GB; Pinsky C
    Res Commun Chem Pathol Pharmacol; 1989 Apr; 64(1):111-9. PubMed ID: 2748994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.